[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4963 followers Created: 2025-07-15 19:31:28 UTC Hengrui Pharma’s Potential Rival to El Lilly’s Zepbound Leads to XX% Weight Loss in Key Study #glp-1marketing #feedly $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS  XXX engagements  **Related Topics** [hims](/topic/hims) [pfe](/topic/pfe) [manat](/topic/manat) [$hims](/topic/$hims) [$vani](/topic/$vani) [$zldpf](/topic/$zldpf) [$rhhby](/topic/$rhhby) [$gsk](/topic/$gsk) [Post Link](https://x.com/AponiaAnalytics/status/1945204588199448973)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4963 followers
Created: 2025-07-15 19:31:28 UTC
Hengrui Pharma’s Potential Rival to El Lilly’s Zepbound Leads to XX% Weight Loss in Key Study #glp-1marketing #feedly $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS
XXX engagements
Related Topics hims pfe manat $hims $vani $zldpf $rhhby $gsk
/post/tweet::1945204588199448973